Follow
Margaretha Morsink
Margaretha Morsink
PhD Candidate at Columbia University
Verified email at columbia.edu
Title
Cited by
Cited by
Year
Nanotoxicology and nanosafety: Safety-by-design and testing at a glance
A Zielińska, B Costa, MV Ferreira, D Miguéis, JMS Louros, A Durazzo, ...
International Journal of Environmental Research and Public Health 17 (13), 4657, 2020
1482020
Biofabrication of natural hydrogels for cardiac, neural, and bone Tissue engineering Applications
K Elkhoury, M Morsink, L Sanchez-Gonzalez, C Kahn, A Tamayol, ...
Bioactive materials 6 (11), 3904-3923, 2021
1172021
Alzheimer’s disease: treatment strategies and their limitations
E Passeri, K Elkhoury, M Morsink, K Broersen, M Linder, A Tamayol, ...
International journal of molecular sciences 23 (22), 13954, 2022
1062022
Applications of natural, semi-synthetic, and synthetic polymers in cosmetic formulations
TFR Alves, M Morsink, F Batain, MV Chaud, T Almeida, DA Fernandes, ...
Cosmetics 7 (4), 75, 2020
922020
Properties, extraction methods, and delivery systems for curcumin as a natural source of beneficial health effects
A Zielińska, H Alves, V Marques, A Durazzo, M Lucarini, TF Alves, ...
Medicina 56 (7), 336, 2020
772020
Immune organs and immune cells on a chip: an overview of biomedical applications
MAJ Morsink, NGA Willemen, J Leijten, R Bansal, SR Shin
Micromachines 11 (9), 849, 2020
502020
Naringenin-functionalized multi-walled carbon nanotubes: a potential approach for site-specific remote-controlled anticancer delivery for the treatment of lung cancer cells
RP Morais, GB Novais, LS Sangenito, ALS Santos, R Priefer, M Morsink, ...
International journal of molecular sciences 21 (12), 4557, 2020
432020
Effects of electrically conductive nano-biomaterials on regulating cardiomyocyte behavior for cardiac repair and regeneration
M Morsink, P Severino, E Luna-Ceron, MA Hussain, N Sobahi, SR Shin
Acta biomaterialia 139, 141-156, 2022
342022
From oral formulations to drug-eluting implants: using 3D and 4D printing to develop drug delivery systems and personalized medicine
NGA Willemen, MAJ Morsink, D Veerman, CF Da Silva, JC Cardoso, ...
Bio-Design and Manufacturing, 1-22, 2021
342021
Synthesis and characterization of C2C12-laden gelatin methacryloyl (GelMA) from marine and mammalian sources
K Elkhoury, M Morsink, Y Tahri, C Kahn, F Cleymand, SR Shin, ...
International Journal of Biological Macromolecules 183, 918-926, 2021
312021
New trends in drug delivery systems for veterinary applications
CF da Silva, T Almeida, R de Melo Barbosa, JC Cardoso, M Morsink, ...
Pharmaceutical Nanotechnology 9 (1), 15-25, 2021
172021
Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery
BZ Wang, TR Nash, X Zhang, J Rao, L Abriola, Y Kim, S Zakharov, M Kim, ...
Cell Reports Medicine 4 (3), 2023
72023
Applications of natural, semi-synthetic, and synthetic polymers in cosmetic formulations. Cosmetics, 7 (4), 75
TF Alves, M Morsink, F Batain, MV Chaud, T Almeida, DA Fernandes, ...
52020
Perillyl alcohol in Solid Lipid Nanoparticles (SLN-PA): Cytotoxicity and antitumor potential in sarcoma 180 mice model
LN Andrade, MSS Cavendish, SPM Costa, RG Amaral, CB Corrêa, ...
Andover House, 2020
32020
Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinetics, Biopharmaceutics, and Biosafety
M Morsink, L Parente, F Silva, A Abrantes, A Ramos, I Primo, N Willemen, ...
Current Pharmaceutical Design 28 (2), 104-115, 2022
22022
An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury
S Fleischer, TR Nash, MA Tamargo, RI Lock, G Venturini, M Morsink, V Li, ...
bioRxiv, 2024.03. 07.583787, 2024
2024
Mapping the Interactome of FLNC in Restrictive Cardiomyopathy
B Wang, X Zhang, L Luo, M Morsink, J Rao, G Vunjak-Novakovic, B Fine
Circulation 148 (Suppl_1), A17551-A17551, 2023
2023
An Engineered Human Cardiac Tissue Model Reveals The Potential Contribution Of Systemic Lupus Erythematosus Autoantibodies To Myocardial Injury
TR Nash, S Fleischer, MA Tamargo, RI Lock, M Morsink, V Li, MJ Lamberti, ...
CIRCULATION RESEARCH 133, 2023
2023
Abstract P2112: Mechanism Of Bag3's Degradation Of Tgfbr2 In Cardiac Fibroblasts
M Morsink, B Wang, J Watkins, L Luo, X Zhang, R Soni, B Fine, ...
Circulation Research 133 (Suppl_1), AP2112-AP2112, 2023
2023
Abstract P1040: An Engineered Human Cardiac Tissue Model Reveals The Potential Contribution Of Systemic Lupus Erythematosus Autoantibodies To Myocardial Injury
TR Nash, S Fleischer, MA Tamargo, RI Lock, M Morsink, V Li, MJ Lamberti, ...
Circulation Research 133 (Suppl_1), AP1040-AP1040, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20